INTRODUCTION AND OBJECTIVES: Limited outcome studies exist for subtypes of continent cutaneous urinary diversions (CCUD). This study evaluates two subtypes of CCUD; Indiana Pouch (IP) and Appendico-umbilicostomy (AU), by investigating diversion-specific complications and quality of life after diversion. METHODS: A retrospective review of an IRB-approved database was conducted for perioperative and outcome data. The EORTC QLQ-C30 questionnaire was used to assess quality of life; all responses were dated >6 months after diversion. RESULTS: 58 patients (33 IP under 2 surgeons, 25 AU under 1 surgeon) were identified for this study (2010-2016). All 3 surgeons were fellowship-trained urologic oncologists. Patient characteristics are summarized in Table 1. Higher age and higher Charlson Comorbidity Index (CCI) !3 were seen in the AU cohort (p[0.002, 0.006, respectively). Outcome data are listed in Table 2. After a median follow up of 21 months (range:0.8-81.0), more stoma complications were reported for the AU cohort (p[0.049). In both types of diversions, >60% of stoma complications occurred at skin/fascia level. In the 90-day postoperative period, a higher continence rate was reported for the IP cohort (p[0.017). 24 responses were recorded for the EORTC questionnaire (14 IP, 10 AU): for both cohorts >70% of patients reported little to no disturbance of daily functions and rated overall quality of life as !70% (Table 3). CONCLUSIONS: The Indiana Pouch and Appendicoumbilicostomy urinary diversions are associated with high rates of continence and patient satisfaction. Stoma complications are common and are mostly seen at superficial level. Our Appendicoumbilicostomy cohort had a higher rate of stoma complication and a lower 90-day continence rate; however, this may be attributed to higher age and CCI in this cohort.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.